Rodney Young

Rodney Young, our Chief Financial Officer, joined Cellerant in June 2015. He comes to Cellerant with significant corporate finance and leadership experience. Mr. Young was previously Chief Financial Officer at StemCells, Inc., a NASDAQ listed, public biotechnology company developing stem cell therapeutics for central nervous system disorders, where he had been responsible for raising over $200 million in financings. Most recently, he served as Chief Financial Officer at Allergen Research Corporation, where he had led the efforts in raising an $80 million private financing round. Earlier in his career, he was an investment banker at Lehman Brothers and SG Cowen, leading financing and merger and acquisition transactions focused in the healthcare, biotechnology, and pharmaceutical sectors. Mr. Young received his BA and MBA from the University of Chicago.


Copyright ©2006-2016 Cellerant Therapeutics, Inc.